Literature DB >> 666828

High concentration of hexacosanoate in cultured skin fibroblast lipids from adrenoleukodystrophy patients.

N Kawamura, A B Moser, H W Moser, T Ogino, K Suzuki, H Schaumburg, A Milunsky, J Murphy, Y Kishimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 666828     DOI： 10.1016/0006-291x(78)90584-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  17 in total

Review 1.  Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein.

Authors:  Martin-Paul Agbaga; Md Nawajes A Mandal; Robert E Anderson
Journal:  J Lipid Res       Date:  2010-03-18       Impact factor: 5.922

Review 2.  Biochemistry of peroxisomes in health and disease.

Authors:  I Singh
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

3.  Adrenoleukodystrophy without adrenal insufficiency and its magnetic resonance imaging.

Authors:  H Nishio; S Kodama; T Tsubota; T Takumi; T Takahashi; S Yokoyama; T Matsuo
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

4.  Defective peroxisomal cleavage of the C27-steroid side chain in the cerebro-hepato-renal syndrome of Zellweger.

Authors:  B F Kase; I Björkhem; P Hågå; J I Pedersen
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

5.  Determination of C20-C30 fatty acids by reversed-phase chromatographic techniques: an efficient method to quantitate minor fatty acids in serum of patients with adrenoleukodystrophy.

Authors:  M Alberghina; A Fiumara; L Pavone; A M Giuffrida
Journal:  Neurochem Res       Date:  1984-12       Impact factor: 3.996

6.  Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy.

Authors:  R A Knazek; W B Rizzo; J D Schulman; J R Dave
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

7.  A combination of spastic paraparesis, polyneuropathy and adrenocortical insufficiency-a childhood form of adrenomyeloneuropathy.

Authors:  K Toifl; B Mamoli; F Waldhauser
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

8.  Neonatal adrenoleukodystrophy: clinical, pathologic, and biochemical delineation of a syndrome affecting both males and females.

Authors:  R Jaffe; P Crumrine; Y Hashida; H W Moser
Journal:  Am J Pathol       Date:  1982-07       Impact factor: 4.307

9.  Adrenoleukodystrophy: a clinical variant presenting as olivopontocerebellar atrophy.

Authors:  T Ohno; H Tsuchida; N Fukuhara; T Yuasa; H Harayama; S Tsuji; T Miyatake
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

10.  Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells.

Authors:  B R Migeon; H W Moser; A B Moser; J Axelman; D Sillence; R A Norum
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.